ARTICLE | Company News
Mucosis, PATH gastrointestinal, drug delivery news
October 11, 2010 7:00 AM UTC
The not-for-profit will provide $600,000 in funding to Mucosis to establish proof-of-concept (POC) in animals of the biotech's Mimopath technology for oral vaccines to prevent and treat severe diarrhe...